It inhibits the cytotoxic capacity of T lymphocytes by binding to its ligand PD-L1, which has been observed in increased numbers in several malignancies and can promote tumor immune escape and T lymphocyte exhaustion (82). The gene discussed is CD274; the disease is neoplasm.